HK1050708A1 - Ehrlichia canis genes and vaccines - Google Patents

Ehrlichia canis genes and vaccines

Info

Publication number: HK1050708A1
Authority: HK; Hong Kong
Prior art keywords: vaccines; ehrlichia canis; genes; canis genes; ehrlichia
Prior art date: 1999-07-21

Application number

HK03101577.6A

Other languages

Chinese (zh)

Inventor

常永福

Original Assignee

Cornell Res Foundation Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-21

Filing date

2003-03-03

Publication date

2003-07-04

2003-03-03 Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc

2003-07-04 Publication of HK1050708A1 publication Critical patent/HK1050708A1/en

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0053—Oxidoreductases (1.) acting on a heme group of donors (1.9)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Investigating Or Analysing Biological Materials (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HK03101577.6A 1999-07-21 2003-03-03 Ehrlichia canis genes and vaccines HK1050708A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US35832299A	1999-07-21	1999-07-21
PCT/US2000/019763 WO2001007625A2 (en)	1999-07-21	2000-07-20	Ehrlichia canis genes and vaccines

Publications (1)

Publication Number	Publication Date
HK1050708A1 true HK1050708A1 (en)	2003-07-04

Family

ID=23409210

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK03101577.6A HK1050708A1 (en)	1999-07-21	2003-03-03	Ehrlichia canis genes and vaccines

Country Status (12)

Country	Link
EP (1)	EP1210438A2 (en)
JP (1)	JP2003505087A (en)
CN (1)	CN1367832A (en)
AU (1)	AU772946B2 (en)
BR (1)	BR0012556A (en)
CA (1)	CA2375650A1 (en)
CZ (1)	CZ2002601A3 (en)
HK (1)	HK1050708A1 (en)
IL (1)	IL147733A0 (en)
MX (1)	MXPA02000748A (en)
WO (1)	WO2001007625A2 (en)
ZA (1)	ZA200200035B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7335754B2 (en)	1999-07-21	2008-02-26	Cornell Research Foundation, Inc.	Ehrlichia canis genes and vaccines
CA2520368C (en)	2002-11-07	2012-09-25	Abbott Laboratories	Method of loading beneficial agent to a prosthesis by fluid-jet application
NZ544011A (en) *	2003-06-10	2009-02-28	Univ Melbourne	Immunomodulating compositions uses therefor and processes for their production
EP2501718B1 (en) *	2009-11-20	2016-07-27	Abaxis, Inc.	Peptides, devices, and methods for the detection of ehrlichia antibodies
US9651546B2 (en)	2012-10-11	2017-05-16	Abaxis, Inc.	Peptides, devices, and methods for the detection of ehrlichia antibodies
US9442112B2 (en)	2014-04-04	2016-09-13	Abaxis, Inc.	Compositions and methods for identifying Ehrlichia species

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6025338A (en) *	1996-10-17	2000-02-15	University Of Florida	Nucleic acid vaccines against rickettsial diseases and methods of use
US6207169B1 (en) *	1997-03-21	2001-03-27	Corixa Corporation	Compounds and methods for the diagnosis and treatment of Ehrlichia infection
WO1998042743A1 (en) *	1997-03-24	1998-10-01	Merial	Canine ehrlichiosis immunogenic and diagnostic compositions and methods
AU748357B2 (en) *	1997-09-19	2002-06-06	Ohio State Research Foundation, The	Outer membrane protein of ehrlichia canis and ehrlichia chaffeensis

2000
- 2000-07-20 CA CA002375650A patent/CA2375650A1/en not_active Abandoned
- 2000-07-20 IL IL14773300A patent/IL147733A0/en not_active IP Right Cessation
- 2000-07-20 WO PCT/US2000/019763 patent/WO2001007625A2/en active IP Right Grant
- 2000-07-20 BR BR0012556-3A patent/BR0012556A/en not_active Application Discontinuation
- 2000-07-20 JP JP2001512891A patent/JP2003505087A/en active Pending
- 2000-07-20 EP EP00948815A patent/EP1210438A2/en not_active Withdrawn
- 2000-07-20 CZ CZ2002601A patent/CZ2002601A3/en unknown
- 2000-07-20 MX MXPA02000748A patent/MXPA02000748A/en active IP Right Grant
- 2000-07-20 AU AU62257/00A patent/AU772946B2/en not_active Ceased
- 2000-07-20 CN CN00810608A patent/CN1367832A/en active Pending
2002
- 2002-01-02 ZA ZA200200035A patent/ZA200200035B/en unknown
2003
- 2003-03-03 HK HK03101577.6A patent/HK1050708A1/en unknown

Also Published As

Publication number	Publication date
BR0012556A (en)	2002-07-02
MXPA02000748A (en)	2003-07-14
CN1367832A (en)	2002-09-04
WO2001007625A2 (en)	2001-02-01
AU6225700A (en)	2001-02-13
WO2001007625A3 (en)	2001-10-11
EP1210438A2 (en)	2002-06-05
IL147733A0 (en)	2002-08-14
JP2003505087A (en)	2003-02-12
CZ2002601A3 (en)	2003-04-16
ZA200200035B (en)	2003-10-02
AU772946B2 (en)	2004-05-13
CA2375650A1 (en)	2001-02-01

Publication	Publication Date	Title
IL145045A0 (en)	2002-06-30	Vaccine
HUP0202885A3 (en)	2004-07-28	Vaccines
HUS1300072I1 (en)	2019-11-28	Vaccine
AU5091201A (en)	2001-10-03	Vegf-modulated genes and methods employing them
AU4433702A (en)	2002-04-29	Vaccines
GB9901254D0 (en)	1999-03-10	Vaccines
GB9915204D0 (en)	1999-09-01	Vaccine
AU2002367753A8 (en)	2003-11-03	Ehrlichia canis genes and vaccines
IL147733A0 (en)	2002-08-14	Ehrlichia canis genes and vaccines
GB9906437D0 (en)	1999-05-12	Vaccine
GB9913327D0 (en)	1999-08-11	Vaccine
GB0004533D0 (en)	2000-04-19	Vaccines
GB9922700D0 (en)	1999-11-24	Vaccine
GB9909072D0 (en)	1999-06-16	Vaccine
GB9915106D0 (en)	1999-09-01	Vaccine
GB9917144D0 (en)	1999-09-22	Vaccine
GB9927336D0 (en)	2000-01-12	Vaccine
GB9925619D0 (en)	1999-12-29	Vaccine
GB9925618D0 (en)	1999-12-29	Vaccine
GB9922703D0 (en)	1999-11-24	Vaccine
GB9922701D0 (en)	1999-11-24	Vaccine
GB9918647D0 (en)	1999-10-13	Vaccine
GB9904408D0 (en)	1999-04-21	Vaccine
GB9905511D0 (en)	1999-05-05	Vaccine
GB9919260D0 (en)	1999-10-20	Vaccine